Skip to content
10-Q

Quarterly Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-12-029416

← back to feed
Filed
May 15, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 11, 2012 21.37M sh
Stockholders Equity Q1 2012 · Mar 31, 2012 −$764.66K
Stockholders Equity Q1 2012 · Dec 31, 2011 −$124.03K
Current Liabilities Q1 2012 · Mar 31, 2012 $2.52M
Current Liabilities Q1 2012 · Dec 31, 2011 $2.31M
Current Assets Q1 2012 · Mar 31, 2012 $1.74M
Current Assets Q1 2012 · Dec 31, 2011 $2.18M
Total Assets Q1 2012 · Mar 31, 2012 $1.75M
Total Assets Q1 2012 · Dec 31, 2011 $2.19M
Operating Cash Flow Q1 2012 · Mar 31, 2011 −$356.15K
Cash And Equivalents Q1 2012 · Mar 31, 2011 $3.17M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $3.52M
Sga Expense Q1 2012 · Mar 31, 2011 $296.34K
Rd Expense Q1 2012 · Mar 31, 2011 $162.05K
Revenue Q1 2012 · Mar 31, 2011 $0